List of works - Giovani Triolo

A 2-year comparative open label randomized study of efficacy and safety of etanercept and infliximab in patients with ankylosing spondylitis

scientific article published on 23 October 2009

Activated IL-22 pathway occurs in the muscle tissues of patients with polymyositis or dermatomyositis and is correlated with disease activity

scientific article published on 05 March 2014

Adult-onset Still's disease: an Italian multicentre retrospective observational study of manifestations and treatments in 245 patients

scientific article

Anti-tumour necrosis factor alpha monoclonal antibody therapy for recalcitrant cerebral vasculitis in a patient with Behçet's syndrome.

scientific article published on March 2003

CC chemokine receptor 5 polymorphism in Italian patients with Behcet's disease

scientific article published on 09 September 2012

Contribution of secretory IgA, polymeric IgA and IgA/secretory component-containing circulating immune complexes to the serum hyper-IgA in diabetes mellitus

scientific article published on 01 July 1984

Detection and characterization of antibodies to polymerized human serum albumin (AAA) by ELISA

scientific article published on 01 August 1983

Disease-associated polymorphisms in ERAP1 do not alter endoplasmic reticulum stress in patients with ankylosing spondylitis

article

Ectopic expression of CXCL13, BAFF, APRIL and LT-β is associated with artery tertiary lymphoid organs in giant cell arteritis.

scientific article published on 20 April 2016

Efficacy and safety of rituximab with and without methotrexate in the treatment of rheumatoid arthritis patients: results from the GISEA register

scientific article

Etanercept maintains the clinical benefit achieved by infliximab in patients with rheumatoid arthritis who discontinued infliximab because of side effects

scientific article published on 12 July 2006

Expression of interleukin-32 in the inflamed arteries of patients with giant cell arteritis.

scientific article

HRCT and scleroderma: semiquantitative evaluation of lung damage and functional abnormalities.

scientific article

Humoral and cell mediated immune response to cow's milk proteins in Behçet's disease

scientific article

IL-33 is overexpressed in the inflamed arteries of patients with giant cell arteritis.

scientific article

IL-34 is overexpressed in the inflamed salivary glands of patients with Sjogren's syndrome and is associated with the local expansion of pro-inflammatory CD14(bright)CD16+ monocytes

scientific article published on 07 February 2013

IgA- and insulin-containing (C3-fixing) circulating immune complexes in diabetes mellitus

scientific article published on 01 February 1984

Immune complex-mediated inhibition of lymphocyte Fc-gamma receptors in the plasma of patients with type 1 (insulin-dependent) diabetes mellitus: association with anti-ssDNA antibodies

scientific article published on 01 February 1990

Increased expression of interleukin-32 in the inflamed ileum of ankylosing spondylitis patients

scientific article published on 30 July 2012

Increased level of H-ferritin and its imbalance with L-ferritin, in bone marrow and liver of patients with adult onset Still's disease, developing macrophage activation syndrome, correlate with the severity of the disease.

scientific article

Inhibition of Fc gamma receptors in the plasma of subjects with Down's syndrome

scientific article published on 01 October 1993

Interleukin (IL)-22 receptor 1 is over-expressed in primary Sjogren's syndrome and Sjögren-associated non-Hodgkin lymphomas and is regulated by IL-18.

scientific article

Interleukin-36α axis is modulated in patients with primary Sjögren's syndrome.

scientific article published on 3 June 2015

International consensus: What else can we do to improve diagnosis and therapeutic strategies in patients affected by autoimmune rheumatic diseases (rheumatoid arthritis, spondyloarthritides, systemic sclerosis, systemic lupus erythematosus, antiphos

scientific article

Is minor salivary gland biopsy more than a diagnostic tool in primary Sjo¨gren׳s syndrome? Association between clinical, histopathological, and molecular features: A retrospective study

scientific article published on 15 May 2014

Jejunoileal bypass as the main procedure in the onset of immune-related conditions: the model of BADAS.

scientific article published on May 2013

Long-term anti-TNF therapy and the risk of serious infections in a cohort of patients with rheumatoid arthritis: comparison of adalimumab, etanercept and infliximab in the GISEA registry

scientific article published on 13 July 2012

Long-term anti-tumour necrosis factor therapy reverses the progression of carotid intima-media thickness in female patients with active rheumatoid arthritis.

scientific article published in December 2009

Macrophage phenotype in the subclinical gut inflammation of patients with ankylosing spondylitis

scientific article

Mesenchymal stromal cells and rheumatic diseases: new tools from pathogenesis to regenerative therapies.

scientific article

Monocytes from patients with rheumatoid arthritis and type 2 diabetes mellitus display an increased production of interleukin (IL)-1β via the nucleotide-binding domain and leucine-rich repeat containing family pyrin 3(NLRP3)-inflammasome activation:

scientific article published on 10 June 2015

NF-kappaB protects Behçet's disease T cells against CD95-induced apoptosis up-regulating antiapoptotic proteins.

scientific article published in July 2005

New approaches in the treatment of Adamantiades-Behçet's disease

scientific article

New insights into the pathogenesis of giant cell arteritis

scientific article published on 4 May 2017

Normal plasma thromboxane B2 (TXB2) and 6-keto-PGF1 alpha levels in childhood diabetes

scientific article published on 01 December 1983

One year study of efficacy and safety of infliximab in the treatment of patients with ocular and neurological Behçet's disease refractory to standard immunosuppressive drugs

scientific article published on 27 October 2009

Over-expression of paneth cell-derived anti-microbial peptides in the gut of patients with ankylosing spondylitis and subclinical intestinal inflammation

scientific article published on 05 August 2010

Overexpression of interleukin-23, but not interleukin-17, as an immunologic signature of subclinical intestinal inflammation in ankylosing spondylitis

scientific article published on 01 April 2009

PLA1/A2 polymorphism of the platelet glycoprotein receptors IIIA in Behçet's disease

scientific article published on July 1, 2011

Pathogenesis of autoimmune diseases associated with 8.1 ancestral haplotype: a genetically determined defect of C4 influences immunological parameters of healthy carriers of the haplotype

scientific article published on 01 September 2003

Pathological implications of Th1/Th2 cytokine genetic variants in Behçet's disease: Data from a pilot study in a Sicilian population.

scientific article

Patient-reported impact of spondyloarthritis on work disability and working life: the ATLANTIS survey

scientific article published on April 2016

Phenotype and functional changes of Vgamma9/Vdelta2 T lymphocytes in Behçet's disease and the effect of infliximab on Vgamma9/Vdelta2 T cell expansion, activation and cytotoxicity.

scientific article

Phosphatidylserine counteracts physiological and pharmacological suppression of humoral immune response.

scientific article published in May 1990

Platelet thromboxane synthesis in treated childhood diabetes mellitus

scientific article published on 01 December 1983

Polymorphism of immunoglobulin enhancer element HS1,2A: allele *2 associates with systemic sclerosis. Comparison with HLA-DR and DQ allele frequency

scientific article

Randomized study of subcutaneous low molecular weight heparin plus aspirin versus intravenous immunoglobulin in the treatment of recurrent fetal loss associated with antiphospholipid antibodies

scientific article (publication date: March 2003)

Response to: 'IL-23 expression and activation of autophagy in synovium and PBMCs of HLA-B27 positive patients with ankylosing spondylitis' by Neerinckx et al

scientific article published on 20 August 2014

Rituximab in primary Sjögren's syndrome: a ten-year journey.

scientific article

Rituximab modulates IL-17 expression in the salivary glands of patients with primary Sjögren’s syndrome

scientific article published on 06 March 2014

Rituximab modulates the expression of IL-22 in the salivary glands of patients with primary Sjogren's syndrome

scientific article published on 21 December 2012

The in vitro addition of methotrexate and/or methylprednisolone determines peripheral reduction in Th17 and expansion of conventional Treg and of IL-10 producing Th17 lymphocytes in patients with early rheumatoid arthritis

scientific article published on 03 May 2014

The role of innate and lymphoid IL-22-producing cells in the immunopathology of primary Sjögren's syndrome.

scientific article published on 04 February 2014

Type 3 innate lymphoid cells producing IL-17 and IL-22 are expanded in the gut, in the peripheral blood, synovial fluid and bone marrow of patients with ankylosing spondylitis.

scientific article published on 22 April 2015

List of works by Giovani Triolo

A 2-year comparative open label randomized study of efficacy and safety of etanercept and infliximab in patients with ankylosing spondylitis

Activated IL-22 pathway occurs in the muscle tissues of patients with polymyositis or dermatomyositis and is correlated with disease activity

Adult-onset Still's disease: an Italian multicentre retrospective observational study of manifestations and treatments in 245 patients

Anti-tumour necrosis factor alpha monoclonal antibody therapy for recalcitrant cerebral vasculitis in a patient with Behçet's syndrome.

CC chemokine receptor 5 polymorphism in Italian patients with Behcet's disease

Contribution of secretory IgA, polymeric IgA and IgA/secretory component-containing circulating immune complexes to the serum hyper-IgA in diabetes mellitus

Detection and characterization of antibodies to polymerized human serum albumin (AAA) by ELISA

Disease-associated polymorphisms in ERAP1 do not alter endoplasmic reticulum stress in patients with ankylosing spondylitis

Ectopic expression of CXCL13, BAFF, APRIL and LT-β is associated with artery tertiary lymphoid organs in giant cell arteritis.

Efficacy and safety of rituximab with and without methotrexate in the treatment of rheumatoid arthritis patients: results from the GISEA register

Etanercept maintains the clinical benefit achieved by infliximab in patients with rheumatoid arthritis who discontinued infliximab because of side effects

Expression of interleukin-32 in the inflamed arteries of patients with giant cell arteritis.

HRCT and scleroderma: semiquantitative evaluation of lung damage and functional abnormalities.

Humoral and cell mediated immune response to cow's milk proteins in Behçet's disease

IL-33 is overexpressed in the inflamed arteries of patients with giant cell arteritis.

IL-34 is overexpressed in the inflamed salivary glands of patients with Sjogren's syndrome and is associated with the local expansion of pro-inflammatory CD14(bright)CD16+ monocytes

IgA- and insulin-containing (C3-fixing) circulating immune complexes in diabetes mellitus

Immune complex-mediated inhibition of lymphocyte Fc-gamma receptors in the plasma of patients with type 1 (insulin-dependent) diabetes mellitus: association with anti-ssDNA antibodies

Increased expression of interleukin-32 in the inflamed ileum of ankylosing spondylitis patients

Increased level of H-ferritin and its imbalance with L-ferritin, in bone marrow and liver of patients with adult onset Still's disease, developing macrophage activation syndrome, correlate with the severity of the disease.

Inhibition of Fc gamma receptors in the plasma of subjects with Down's syndrome

Interleukin (IL)-22 receptor 1 is over-expressed in primary Sjogren's syndrome and Sjögren-associated non-Hodgkin lymphomas and is regulated by IL-18.

Interleukin-36α axis is modulated in patients with primary Sjögren's syndrome.

International consensus: What else can we do to improve diagnosis and therapeutic strategies in patients affected by autoimmune rheumatic diseases (rheumatoid arthritis, spondyloarthritides, systemic sclerosis, systemic lupus erythematosus, antiphos

Is minor salivary gland biopsy more than a diagnostic tool in primary Sjo¨gren׳s syndrome? Association between clinical, histopathological, and molecular features: A retrospective study

Jejunoileal bypass as the main procedure in the onset of immune-related conditions: the model of BADAS.

Long-term anti-TNF therapy and the risk of serious infections in a cohort of patients with rheumatoid arthritis: comparison of adalimumab, etanercept and infliximab in the GISEA registry

Long-term anti-tumour necrosis factor therapy reverses the progression of carotid intima-media thickness in female patients with active rheumatoid arthritis.

Macrophage phenotype in the subclinical gut inflammation of patients with ankylosing spondylitis

Mesenchymal stromal cells and rheumatic diseases: new tools from pathogenesis to regenerative therapies.

Monocytes from patients with rheumatoid arthritis and type 2 diabetes mellitus display an increased production of interleukin (IL)-1β via the nucleotide-binding domain and leucine-rich repeat containing family pyrin 3(NLRP3)-inflammasome activation:

NF-kappaB protects Behçet's disease T cells against CD95-induced apoptosis up-regulating antiapoptotic proteins.

New approaches in the treatment of Adamantiades-Behçet's disease

New insights into the pathogenesis of giant cell arteritis

Normal plasma thromboxane B2 (TXB2) and 6-keto-PGF1 alpha levels in childhood diabetes

One year study of efficacy and safety of infliximab in the treatment of patients with ocular and neurological Behçet's disease refractory to standard immunosuppressive drugs

Over-expression of paneth cell-derived anti-microbial peptides in the gut of patients with ankylosing spondylitis and subclinical intestinal inflammation

Overexpression of interleukin-23, but not interleukin-17, as an immunologic signature of subclinical intestinal inflammation in ankylosing spondylitis

PLA1/A2 polymorphism of the platelet glycoprotein receptors IIIA in Behçet's disease

Pathogenesis of autoimmune diseases associated with 8.1 ancestral haplotype: a genetically determined defect of C4 influences immunological parameters of healthy carriers of the haplotype

Pathological implications of Th1/Th2 cytokine genetic variants in Behçet's disease: Data from a pilot study in a Sicilian population.

Patient-reported impact of spondyloarthritis on work disability and working life: the ATLANTIS survey

Phenotype and functional changes of Vgamma9/Vdelta2 T lymphocytes in Behçet's disease and the effect of infliximab on Vgamma9/Vdelta2 T cell expansion, activation and cytotoxicity.

Phosphatidylserine counteracts physiological and pharmacological suppression of humoral immune response.

Platelet thromboxane synthesis in treated childhood diabetes mellitus

Polymorphism of immunoglobulin enhancer element HS1,2A: allele *2 associates with systemic sclerosis. Comparison with HLA-DR and DQ allele frequency

Randomized study of subcutaneous low molecular weight heparin plus aspirin versus intravenous immunoglobulin in the treatment of recurrent fetal loss associated with antiphospholipid antibodies

Response to: 'IL-23 expression and activation of autophagy in synovium and PBMCs of HLA-B27 positive patients with ankylosing spondylitis' by Neerinckx et al

Rituximab in primary Sjögren's syndrome: a ten-year journey.

Rituximab modulates IL-17 expression in the salivary glands of patients with primary Sjögren’s syndrome

Rituximab modulates the expression of IL-22 in the salivary glands of patients with primary Sjogren's syndrome

The in vitro addition of methotrexate and/or methylprednisolone determines peripheral reduction in Th17 and expansion of conventional Treg and of IL-10 producing Th17 lymphocytes in patients with early rheumatoid arthritis

The role of innate and lymphoid IL-22-producing cells in the immunopathology of primary Sjögren's syndrome.

Type 3 innate lymphoid cells producing IL-17 and IL-22 are expanded in the gut, in the peripheral blood, synovial fluid and bone marrow of patients with ankylosing spondylitis.